Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease

Nat Genet. 1994 May;7(1):74-8. doi: 10.1038/ng0594-74.

Abstract

Several studies have reported an association of the apolipoprotein E allele epsilon 4 (APOE*4) to familial and sporadic late-onset Alzheimer's disease (LOAD). Here we report on the relationship between APOE*4 and early-onset Alzheimer's disease (EOAD) in a Dutch population-based study. The frequency of the APOE*4 allele was 2.3 times higher among EOAD cases compared to controls. Among patients, the allele frequency was 1.6 times higher in those with a positive family history than in those without. A significant increase in risk of EOAD was found for subjects homozygous for APOE*4 regardless of family history of dementia, but an increase in EOAD risk for APOE*4 heterozygotes could only be shown in subjects with a positive family history. Our study demonstrates a significant association between APOE*4 and EOAD which is modified by family history of dementia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age of Onset
  • Aged
  • Alleles*
  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / genetics*
  • Apolipoprotein E4
  • Apolipoproteins E / genetics*
  • Family Health
  • Female
  • Gene Frequency
  • Genes, Dominant
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Netherlands / epidemiology
  • Odds Ratio
  • Polymerase Chain Reaction
  • Risk Factors

Substances

  • Apolipoprotein E4
  • Apolipoproteins E